Beginning in June 2020 The Lead Left published a series of articles on post-pandemic healthcare. This report consolidates those articles.
Beginning in March 2018 The Lead Left published a series of articles on the healthcare industry. This report consolidates those articles.
We close our special healthcare series with a discussion of risk. “Increased risk is one of the primary concerns we consider,” said Rod Rivera, managing director in Capstone Headwaters’ healthcare practice. “The world of healthcare, as you’ve been detailing, is changing. All the subsectors that have great CEOs and built the best platforms are asking,
We caught up recently with a banker friend – a veteran of the healthcare industry – to ask him for his thoughts on the state of the sector today: “You’ve touched on a key trend in your series,” he told us: “the transition from fee-for-service to fee-for-value. Providers used to be reimbursed for costs incurred
So far in our healthcare series, we’ve shown a sampling of private equity and advisory perspectives. This week we get views from lenders in the sector. One specialist was instructive. “Healthcare remains local,” she told us. “Florida, for example, is a very different market than the rest of the country. This makes it tough for
One of the most interesting features of the new healthcare landscape is the evolving relationship between patients and doctors. As we detailed in our first instalment of this special Lead Left series, retail giants are teaming with healthcare behemoths to capture patients wherever they go. That fits well with the 24/7, wanting everything all the
“Everyone is fighting for the primary care patient right now.” So said the CEO of a large independent physician practice in New Jersey. This battleground is taking place not just in doctors’ offices, but increasingly in malls, drug store chains, corporate headquarters, urgent care clinics, and retail care centers. Peter Magas, a managing director at
News last week that Walmart was hooking up with Humana sent waves through the healthcare and retail world. Disruption has taken its toll on both sectors. Top players are actively looking across industry lines for partners to help them survive and thrive. Figuring out how to leverage expertise to consolidate inefficient businesses is, of course,
We continue our special series on healthcare with a look this week at how the sector is playing out in the capital markets. (See also our Lead Lead Spotlight with Brad Raymond, Head of Investment Banking at Stifel Financial). As we covered last week, healthcare benefits from tailwinds unique to the industry. Those characteristics have
The private equity firm Platinum Equity announced last week they had offered to buy Johnson & Johnson’s blood glucose monitoring product for about $2.1 billion. The LifeScan Inc unit was one of several J&J businesses focused on diabetes devices. The medical products giant had apparently experienced declining revenues and squeezed margins in that arena and